Intravenous arachidonate in the mouse: A model for the evaluation of antithrombotic drugs
- 1 July 1976
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 9 (1), 67-80
- https://doi.org/10.1016/0049-3848(76)90150-x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Prostaglandin D2 as a potential antithrombotic agentProstaglandins, 1975
- An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significanceProstaglandins, 1974
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974
- Arachidonic acid-induced human platelet aggregation and prostaglandin formationProstaglandins, 1973
- Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2Nature New Biology, 1973
- Formation of Prostaglandins during the Aggregation of Human Blood PlateletsJCI Insight, 1973
- Prostaglandin E2: Effects on aggregation, shape change and cyclic AMP of rat plateletsProstaglandins, 1972
- The Effect of Prostaglandin E1 on Platelet Function in Vitro and in VivoBritish Journal of Haematology, 1970
- Relationship between chemical structure and plateletaggregation activity of prostaglandinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.BMJ, 1967